Cardinal Health is removing a list of its own brand of Monoject sterile syringes from the U.S. market, the company said Friday, expanding on previous actions to address compatibility problems with infusion pumps.
The product removal supersedes two communications Cardinal issued last year after learning that some Monoject syringes are incompatible with certain infusion pumps. Cardinal apologized for “any frustration these changes and resulting issues have caused” and said the latest notice is intended to “reduce confusion and create a simplified course of action” for customers. 18g hypodermic needle
The company has not received any reports of patient death, but noted the potential risk of serious injury or death. The failure of an infusion pump to recognize a syringe could delay treatment. Alternatively, if a syringe is recognized, the pump may provide too much or too little medicine.
High Quality Plastic Injection Mold In September, Cardinal told customers about “recognition and compatibility issues” between Monoject sterile syringes and syringe pumps. The Food and Drug Administration categorized the notice as a Class I recall in November, noting that the recall did not require